4.5 Review

How it all Started: Tau and Protein Phosphatase 2A

Journal

JOURNAL OF ALZHEIMERS DISEASE
Volume 37, Issue 3, Pages 483-494

Publisher

IOS PRESS
DOI: 10.3233/JAD-130503

Keywords

Alzheimer's disease; frontotemporal dementia; nucleus; protein phosphatase 2A; SFPQ; tau; transcription factor

Categories

Funding

  1. Australian Research Council
  2. National Health and Medical Research Council of Australia

Ask authors/readers for more resources

This review is dedicated to Inge Grundke-Iqbal who laid the foundations of the tau field, by isolating tau from the Alzheimer's disease (AD) brain, discovering that tau is hyperphosphorylated, and proving a critical role of protein phosphatase 2A (PP2A) and its endogenous inhibitor I-2 (PP2A) in this process. This memorial starts with a few personal notes, and then covers how subcellular fractionation helped in isolating tau. We review in detail the role of PP2A and its endogenous inhibitor in tau phosphorylation. We discuss the role that methylation and phosphorylation have in regulating PP2A activity. We add what we have contributed to understanding the role of tau and PP2A in AD using PP2A transgenic and knockout models, and conclude by addressing two underexplored areas in tau research: tau's non-canonical functions and the role distinct tau isoforms have in a physiological context.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available